Kraj: Irlandia
Język: angielski
Źródło: HPRA (Health Products Regulatory Authority)
TOLTERODINE TARTRATE
IPS Healthcare Limited
TOLTERODINE TARTRATE
4 Milligram
Prolonged Release Capsules
Product subject to prescription which may be renewed (B)
Withdrawn
2013-03-29
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Detrusitol SR 4mg Prolonged-release Capsules, Hard 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each prolonged-release capsule contains tolterodine tartrate 4mg corresponding to 2.74mg tolterodine. Each 4 mg prolonged-release capsule contains a maximum of 123.07 mg of sucrose. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Prolonged-release capsule, hard _Product imported from the UK._ The 4 mg prolonged-release capsule is blue with white printing (symbol and 4). 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults (including the elderly): The recommended dose is 4 mg once daily except in patients with impaired liver function or severely impaired renal function (GFR 30 ml/min) for whom the recommended dose is 2 mg once daily _(see sections 4.4 and 5.2). _In case of troublesome side-effects the dose may be reduced from 4 mg to 2 mg once daily. The prolonged-release capsules can be taken with or without food and must be swallowed whole. The effect of treatment should be re-evaluated after 2-3 months _(see section 5.1)._ Paediatric patients: Efficacy of Detrusitol SR has not been demonstrated in children _(See section 5.1). _Therefore, Detrusitol SR is not recommended for children. 4.3 CONTRAINDICATIONS Tolterodine is contraindicated in patients with o Urinary retention o Uncontrolled narrow angle glaucoma o Myasthenia gravis o Known hypersensitivity to tolterodine or excipients o Severe ulcerative colitis o Toxic megacolon IRISH MEDICINES BOARD ___________________________________________________________________________________ Przeczytaj cały dokument